Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Khai-Chi Hu

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Clinical Therapeutics|January 5, 2025
Meta-Analysis of Randomized, Controlled Trials Assessing the Effectiveness and Safety of Biological Treatments in Chronic Obstructive Pulmonary Disease PatientsKhai-Chi Hu, Min-Hsiang Chuang, Chih-Cheng Lai, et al.
American Journal of Therapeutics|March 7, 2019
Lurasidone-Induced Delirious ManiaLi-Xian Yeo, Ting-Chun Kuo, Khai-Chi Hu, et al.
Communications Medicine|October 16, 2025
Angiotensin receptor-neprilysin inhibitor treatment in people with chronic obstructive pulmonary disease and heart failureWan-Hsuan Hsu, Bo-Wen Shiau, Jheng-Yan Wu, et al.
Nature Communications|July 2, 2025
The clinical effectiveness of sodium-glucose co-transporter-2 inhibitors on prognosis of patients with chronic obstructive pulmonary disease and diabetesJheng-Yan Wu, Khai-Chi Hu, Mei-Yuan Liu, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Clinical Therapeutics|January 5, 2025
Meta-Analysis of Randomized, Controlled Trials Assessing the Effectiveness and Safety of Biological Treatments in Chronic Obstructive Pulmonary Disease PatientsKhai-Chi Hu, Min-Hsiang Chuang, Chih-Cheng Lai, et al.
American Journal of Therapeutics|March 7, 2019
Lurasidone-Induced Delirious ManiaLi-Xian Yeo, Ting-Chun Kuo, Khai-Chi Hu, et al.
Communications Medicine|October 16, 2025
Angiotensin receptor-neprilysin inhibitor treatment in people with chronic obstructive pulmonary disease and heart failureWan-Hsuan Hsu, Bo-Wen Shiau, Jheng-Yan Wu, et al.
Nature Communications|July 2, 2025
The clinical effectiveness of sodium-glucose co-transporter-2 inhibitors on prognosis of patients with chronic obstructive pulmonary disease and diabetesJheng-Yan Wu, Khai-Chi Hu, Mei-Yuan Liu, et al.
Pageof 1